InspireMD, Inc. – NASDAQ:NSPR
InspireMD stock price today
InspireMD stock price monthly change
InspireMD stock price quarterly change
InspireMD stock price yearly change
InspireMD key metrics
Market Cap | 74.59M |
Enterprise value | 5.32M |
P/E | -0.48 |
EV/Sales | 1.02 |
EV/EBITDA | -0.29 |
Price/Sales | 1.69 |
Price/Book | 0.50 |
PEG ratio | 0.03 |
EPS | -0.85 |
Revenue | 6.47M |
EBITDA | -23.98M |
Income | -22.69M |
Revenue Q/Q | 21.95% |
Revenue Y/Y | 23.91% |
Profit margin | -357.59% |
Oper. margin | -361.88% |
Gross margin | 21.6% |
EBIT margin | -361.88% |
EBITDA margin | -370.36% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInspireMD stock price history
InspireMD stock forecast
InspireMD financial statements
| Jun 2023 | 1.64M | -5.07M | -307.88% |
|---|---|---|---|
| Sep 2023 | 1.55M | -5.17M | -332.78% |
| Dec 2023 | 1.76M | -5.40M | -306.93% |
| Mar 2024 | 1.51M | -7.03M | -465.39% |
| Mar 2024 | 1.51M | -7.03M | -465.39% |
|---|---|---|---|
| Sep 2025 | 3.43M | 0 | |
| Oct 2025 | 2.72M | -6.50M | -238.5% |
| Dec 2025 | 3.52M | -6.84M | -194.56% |
Analysts Price target
Financials & Ratios estimates
| 2023-05-15 | -0.68 | -0.57 |
|---|
| Jun 2023 | 53638000 | 6.82M | 12.72% |
|---|---|---|---|
| Sep 2023 | 50020000 | 6.76M | 13.52% |
| Dec 2023 | 47643000 | 8.14M | 17.09% |
| Mar 2024 | 42028000 | 6.94M | 16.52% |
| Jun 2023 | -3.32M | -26.89M | 37.53M |
|---|---|---|---|
| Sep 2023 | -4.04M | 6.38M | 0 |
| Dec 2023 | -4.17M | -36K | 0 |
| Mar 2024 | -5.06M | 4.81M | 0 |
InspireMD alternative data
| Aug 2023 | 55 |
|---|---|
| Sep 2023 | 55 |
| Oct 2023 | 55 |
| Nov 2023 | 55 |
| Dec 2023 | 55 |
| Jan 2024 | 55 |
| Feb 2024 | 55 |
| Mar 2024 | 65 |
| Apr 2024 | 65 |
| May 2024 | 65 |
| Jun 2024 | 68 |
| Jul 2024 | 68 |
InspireMD other data
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 1259985 | 0 |
| Nov 2023 | 50000 | 0 |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 6 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 6 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of InspireMD stock today?
One share of InspireMD stock can currently be purchased for approximately $2.54.
-
When is InspireMD's next earnings date?
Unfortunately, InspireMD's (NSPR) next earnings date is currently unknown.
-
Does InspireMD pay dividends?
No, InspireMD does not pay dividends.
-
How much money does InspireMD make?
InspireMD has a market capitalization of 74.59M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20% to 6.21M US dollars. InspireMD made a loss 19.92M US dollars in net income (profit) last year or -$0.57 on an earnings per share basis.
-
What is InspireMD's stock symbol?
InspireMD, Inc. is traded on the NASDAQ under the ticker symbol "NSPR".
-
What is InspireMD's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of InspireMD?
Shares of InspireMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are InspireMD's key executives?
InspireMD's management team includes the following people:
- Mr. Marvin L. Slosman Pres, Chief Executive Officer & Director(age: 60, pay: $526,980)
- Mr. Craig Shore Chief Financial Officer, Chief Admin. Officer, Sec. & Treasurer(age: 64, pay: $525,320)
-
How many employees does InspireMD have?
As Jul 2024, InspireMD employs 68 workers, which is 5% more then previous quarter.
-
When InspireMD went public?
InspireMD, Inc. is publicly traded company for more then 14 years since IPO on 12 Apr 2011.
-
What is InspireMD's official website?
The official website for InspireMD is inspiremd.com.
-
How can i contact InspireMD?
InspireMD can be reached via phone at +888 7766804.
InspireMD company profile:
InspireMD, Inc.
inspiremd.comNASDAQ
65
Medical - Devices
Healthcare
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Tel Aviv, 6744832
CIK: 0001433607
ISIN: US45779A8466
CUSIP: 45779A853
